CTC
IHE icon

Central Trust Company’s iShares US Pharmaceuticals ETF IHE Stock Holding History

Central Trust Company’s Portfolio IHE Stock Details IHE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-1,605
Closed -$83K – 1295
2017
Q2 		$83K Hold
1,605
– – 0.01% 594
2017
Q1 		$81K Hold
1,605
– – 0.01% 604
2016
Q4 		$76K Buy
+1,605
New +$76.2K 0.01% 611

Other funds holding IHE

CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
AWA
ARS Wealth Advisors St. Petersburg, Florida $556M AUM 30.03% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
RTS
Round Table Services Westfield, New Jersey $508M AUM 16.36% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Central Trust Company's IHE Position: Q3 2017 in Review

Central Trust Company sold out of iShares US Pharmaceuticals ETF (IHE) in Q3 2017, closing a stake of 1,605 shares — an estimated $83K sold.

Central Trust Company first reported a position in IHE in Q4 2016 and held it in 3 quarters. The position peaked at $83K in Q2 2017. 101 funds tracked by Wall St. Rank hold IHE as of Q3 2017.

  • Central Trust Company reported no remaining iShares US Pharmaceuticals ETF position as of Q3 2017 after selling out during the quarter.
  • Central Trust Company sold 1,605 iShares US Pharmaceuticals ETF shares in Q3 2017, an estimated $83K.
  • Central Trust Company first reported a position in iShares US Pharmaceuticals ETF in Q4 2016 and held it in 3 quarters.
  • Central Trust Company's iShares US Pharmaceuticals ETF position peaked at $83K in Q2 2017.
  • 101 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q3 2017.

Based on Central Trust Company's 13F filing for Q3 2017, filed 17 Oct 2017.